Our research identifies the safety and efficacy of an orally administered CBD/CBG tincture in adults with active symptoms of irritable bowel syndrome. IBS affects 15% of the population of the U.S. and available conventional medical therapy is of limited efficacy. Safe and natural therapy has long been desired and sought and we are very excited about these initial results and how they can naturally help millions of people daily, said Dr. Good.
The clinical trials and open label studies such as the one performed by Dr. Good for IBS are exactly what is required to bring CBD/CBG and the many other cannabinoids to the forefront of natural ingredients for health and wellness, managed properly.